Child and Adolescent Clinical Psychopharmacology Made Simple

D. Preston John

Sujets

• Médecine
• Psychiatry
• Psychotherapy

Informations

• Publié par: New Harbinger Publications
• Date de parution: 01 décembre 2020
• Nombre de lectures: 0
• EAN13: 9781684035144
• Langue: English
• Poids de l'ouvrage: 1 Mo

Extrait

“This book is remarkable in its ability to communicate essential, factual, and practical information in a concise and easily readable manner. Each chapter manages to succinctly provide the reader with information about diagnostic considerations, clinical signs and symptoms of the disorder, and the most effective and up-to-date approaches to treatment. I would recommend this book for students, professionals, individuals who live with the disorders, and their families/caregivers.”
—Joseph E. Comaty, PhD, MP , clinical psychologist, medical psychologist (Louisiana), and coauthor of Julien’s Primer of Drug Action
“The fourth edition of Child and Adolescent Clinical Psychopharmacology Made Simple presents pediatric disorders and their treatments in a highly readable and well-organized style. Not only are agents formally approved for pediatric use covered, but so are the many drugs frequently prescribed ‘off-label.’ Numerous tips are also included on how pediatric management both overlaps and differs from adults. A must-read for those learning to treat children and adolescents.”
—Stephen Stahl, MD, PhD, DSc , professor of psychiatry at the University of California, Riverside; honorary fellow of the University of Cambridge; and author of more than 500 scientific papers and sixty books on psychiatry and psychopharmacology
“This book offers a clear review of the medications used to treat the most common psychiatric conditions in children. The ample use of tables and boxes makes information such as dosing and common side effects readily accessible. Additional information about over-the-counter agents and dietary supplements—as well as patient information sheets about specific classes of medications—provides an added benefit of great practical value to both parents and early career professionals.”
—Jacobus Donders, PhD, ABPP , chief psychologist at Mary Free Bed Rehabilitation Hospital, and coeditor of Clinical Neuropsychology Study Guide and Board Review
“This well-written and easy-to-read book puts at your fingertips a quick reference for those who diagnose and treat children and adolescents with psychiatric disorders. Outside of the basics, it provides the reader with a sense that the authors, outside of being experts, treat patients in their own practices and live by what they teach in their writing of this book.”
—Thomas L. Schwartz, MD , author of Practical Psychopharmacology , and professor and interim chair of psychiatry at SUNY Upstate Medical University
Praise from Previous Editions
“ Child and Adolescent Psychopharmacology Made Simple is an outstanding contribution for the non-pharmacist health professional. The chapters are clear, practical, concise, and authored by pharmacists, physicians, and behavioral health experts with current knowledge and valuable insights for health professionals working in medical, dental, and behavioral health settings.”
—William Gordon, PhD , president of the Institute for Brain Potential
“This is a great handbook that is up to date and very clearly written. The short chapters and multiple tables make it extremely easy to use. I find it ideal when I need quick access to information on the latest psychopharmaceuticals for kids.”
—Daniel Carlat, MD , associate clinical professor of psychiatry at Tufts University School of Medicine, and publisher of The Carlat Psychiatry Report


Publisher’s Note
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold with the understanding that the publisher is not engaged in rendering psychological, financial, legal, or other professional services. If expert assistance or counseling is needed, the services of a competent professional should be sought.
Chapter 10 of this text, “Over-the-Counter Medications and Dietary Supplements,” is adapted from Clinical Psychopharmacology Made Ridiculously Simpl e ™ (8th ed.), by John D. Preston and James Johnson. Copyright © 2014 John D. Preston and James Johnson. Used by permission of MedMaster, Inc.
Distributed in Canada by Raincoast Books
Copyright © 2021 by John Preston, John H. O’Neal, Mary C. Talaga, & Bret Moore New Harbinger Publications, Inc. 5674 Shattuck Avenue Oakland, CA 94609 www.newharbinger.com
All Rights Reserved
Acquired by Jennye Garibaldi; Cover design by Amy Shoup; Text design by Tracy Marie Carlson
Library of Congress Cataloging-in-Publication Data on file
To my grandsons, Atticus and Ender: identical and so unique!
—JP
In memory of Patrick Everette Cummings. …Your spirit lives on.
—MT
To my patients, for they have been my best teachers.
—JO
To my wife Lori and her unshakable support, and daughter Kaitlyn and her perpetual inspiration.
—BAM


Contents
Acknowledgments
Introduction: Sharing Our Concerns: For H+ealth Care Providers, Parents, and Patients
CHAPTER 1: Issues in Psychopharmacological Treatment of Children and Adolescents
CHAPTER 2: Depression
CHAPTER 3: Bipolar Disorder
CHAPTER 4: Anxiety Disorders
CHAPTER 5: Psychotic Disorders
CHAPTER 6: Attention-Deficit/ Hyperactivity Disorder
CHAPTER 7: Autism Spectrum Disorder
CHAPTER 8: Sleep Disorders
CHAPTER 9: Miscellaneous Disorders
CHAPTER 10: Over- the- Counter Medications and Dietary Supplements
Appendix: Patient and Caregiver Information Sheets on Psychiatric Medications
References
Index
Acknowledgments
Many thanks to our publisher, Dr. Matthew McKay, freelance copy editor Gretel Hakanson, and our most excellent editors, Melissa Kirk, Catharine Meyers, Karen O’Donnell Stein, and Kayla Sussell.
Thanks to our families, with deep appreciation for their patience and encouragement.
Finally, a heartfelt thanks to our patients.
May this book help our fellow mental health clinicians in our shared and ongoing struggle to reduce emotional suffering in young people.
Introduction: Sharing Our Concerns: For H+ealth Care Providers, Parents, and Patients
Facts without values, fragmentary specialties with no integrating philosophy of life as a whole, data with no ethical standards for their use, techniques … with no convictions about life’s ultimate meaning … here a panacea has turned out to be a problem.
—Harry Emerson Fosdick The Living of These Days (1956)
Many young people experience considerable emotional suffering. Oftentimes this psychological pain is associated with poverty, poor prenatal care, racial or other forms of discrimination, serious family dysfunction, traumatic life events, or any of a host of neuropsychiatric disorders. Only certain types of emotional distress are appropriate for treatment with psychiatric medications.
Psychiatric medication treatment of children and teenagers began in the 1960s. Yet only recently have large-scale medication trials been conducted. The research in child psychiatry is still considered to be limited. Clearly advances have been made, both in the safety of medications and in the development of treatment guidelines. In this book we summarize basic information regarding classes of psychological disorders for which medications are often prescribed, and we present current guidelines for the use of medications. However, we first want to state three important and overarching concerns.
The first concern is that in the current era of managed care, it is common for insufficient time or attention to be given to conducting a comprehensive history and diagnostic evaluation. Such an evaluation is essential before any recommendation can be made regarding treatment. Second, it is clear that when psychiatric medications are used to treat particular disorders, close follow-up is warranted and essential for addressing problems of treatment adherence, managing side effects, and monitoring response to treatment. Third, most children and teenagers suffering from psychological problems do not require medication treatment; instead, they may need psychosocial interventions, often involving the family as well as the individual. Even in those conditions that are judged to be largely neurobiological in nature and responsive to medication treatments, psychotherapy is always indicated.
In voicing these three issues, it may seem as if we are just stating the obvious; however, our concern is that with the quick-fix and get-on-with-your-life mentality in our social culture and the health care industry’s focus on cost containment, the knee-jerk reaction of too many providers may be to reach for the prescription pad whenever they see psychological symptoms. While the appropriate use of psychiatric medications has helped many young people, we feel it’s important for us to strongly endorse a comprehensive approach to treatment. This approach should be based on careful evaluations, close monitoring, and the use of psychotherapy, with medications prescribed only if warranted.
It is also important for clinicians, consumers, and parents alike to be aware of the risks and benefits of all treatments. Because of the enormous complexity of human psychological functioning, most problems are multi dimensional and require interventions on a number of levels. And it is equally important to be humble regarding our approaches to treatment. Psychiatric drugs, as we shall see in this volume, can reduce rates of suicide, may decrease the risk of substance abuse, and in some instances may prevent certain kinds of brain damage. But medical treatments also have clear limits; there are no panaceas. No drug can mend a broken heart, fill an empty life, or teach parents how to love their children.
CHAPTER 1: Issues in Psychopharmacological Treatment of Children and Adolescents
In this first chapter we address a number of general issues that are important to